Explore
Validate
Learn3035
antibody from Cell Signaling Technology, Inc
Targeting: NFKB1
KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3035 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3035, RRID:AB_330564
- Product name
- NF-κB1 p105/p50 Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes.
Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling.
Kwong C, Gilman-Sachs A, Beaman K
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1781-9
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1781-9
Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling.
Rajendrasozhan S, Chung S, Sundar IK, Yao H, Rahman I
American journal of physiology. Lung cellular and molecular physiology 2010 Feb;298(2):L197-209
American journal of physiology. Lung cellular and molecular physiology 2010 Feb;298(2):L197-209
No comments: Submit comment
No validations: Submit validation data